Liverppol
Seqirus announces £40m UK fill-and-finish flu vaccine facility
November 9, 2017Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus
Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
